Literature DB >> 19554481

The premenstrual syndrome and fibromyalgia--similarities and common features.

Daniela Amital1, Calanit Herskovitz, Leah Fostick, Alysa Silberman, Yariv Doron, Joseph Zohar, Alek Itsekson, Matityahu Zolti, Alan Rubinow, Howard Amital.   

Abstract

The aim of the study was to assess the clinical similarities and common features of fibromyalgia syndrome (FM) and premenstrual dysphoric syndrome (PMDD). Thirty young patients who met the diagnostic criteria for PMDD were included in the study and compared to 26 women belonging to the medical staff of a general psychiatry department. All enrollees were interviewed and examined by a skilled physician. They completed the following nine survey items: demographic information, clinical health assessment questionnaire, fibromyalgia impact questionnaire, sleep and fatigue questionnaires, Sheehan disability scales, SF-36 assessment for quality of life, visual analog scale for pain, Mini International Neuropsychiatric Interview (MINI) questionnaire (assessment of coexistent psychiatric conditions), and the premenstrual severity scale. Additionally, each individual underwent a physical examination measuring the classical tender points and was asked to describe the distribution and continuum of her pain or tenderness. The PMDD group scored significantly higher in the measures pain and tenderness as well as in severity of premenstrual symptoms compared to the control group. Five patients in the PMDD group and none in the control group had FM. Quality of life measured by the SF-36 was higher in the control group than in the PMDD group and correlated with the degree of tenderness reported. Psychiatric comorbidity was significantly more common in the PMDD group, affecting 16 of the 30 PMDD patients compared to only three of the 26 control patients. In this study, patients with PMDD were found to have higher levels of tenderness, higher psychiatric comorbidity, greater level of physical disabilities, and a lower quality of life. These parameters were highly correlated with a lower pain threshold.

Entities:  

Mesh:

Year:  2010        PMID: 19554481     DOI: 10.1007/s12016-009-8143-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  48 in total

1.  The role of sex hormones in pain response.

Authors:  K R Johns; G O Littlejohn
Journal:  Pain       Date:  1999-10       Impact factor: 6.961

Review 2.  Diagnosis and treatment of premenstrual dysphoric disorder: an update.

Authors:  M Steiner; L Born
Journal:  Int Clin Psychopharmacol       Date:  2000-11       Impact factor: 1.659

3.  Beta-endorphin decline in late luteal phase dysphoric disorder.

Authors:  A J Giannini; D M Martin; C E Turner
Journal:  Int J Psychiatry Med       Date:  1990       Impact factor: 1.210

4.  Posttraumatic stress disorder screening status is associated with increased VA medical and surgical utilization in women.

Authors:  Dorcas J Dobie; Charles Maynard; Daniel R Kivlahan; Kay M Johnson; Tracy Simpson; Andrew C David; Katharine Bradley
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

Review 5.  Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Authors:  Meir Steiner; Teri Pearlstein; Lee S Cohen; Jean Endicott; Susan G Kornstein; Carla Roberts; David L Roberts; Kimberly Yonkers
Journal:  J Womens Health (Larchmt)       Date:  2006 Jan-Feb       Impact factor: 2.681

6.  Pain perception across the menstrual cycle phases in women with chronic pain.

Authors:  Birgitta Hellström; Ulla Maria Anderberg
Journal:  Percept Mot Skills       Date:  2003-02

Review 7.  New roles for estrogen receptor beta in behavior and neuroendocrinology.

Authors:  Cristian Bodo; Emilie F Rissman
Journal:  Front Neuroendocrinol       Date:  2006-04-17       Impact factor: 8.606

8.  Sex hormonal factors and chronic widespread pain: a population study among women.

Authors:  T V Macfarlane; A Blinkhorn; H V Worthington; R M Davies; G J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

9.  Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder.

Authors:  Patricia A Straneva; William Maixner; Kathleen C Light; Cort A Pedersen; Nancy L Costello; Susan S Girdler
Journal:  Health Psychol       Date:  2002-07       Impact factor: 4.267

10.  Menstrual cycle modulation of tender points.

Authors:  Eleni G Hapidou; Gary B Rollman
Journal:  Pain       Date:  1998-08       Impact factor: 6.961

View more
  3 in total

1.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

2.  Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis.

Authors:  Howard Amital; Nancy Agmon-Levin; Netta Shoenfeld; Yoav Arnson; Daniela Amital; Pnina Langevitz; Alexandra Balbir Gurman; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  Central sensitization: implications for the diagnosis and treatment of pain.

Authors:  Clifford J Woolf
Journal:  Pain       Date:  2010-10-18       Impact factor: 6.961

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.